Pharmafile Logo
Pharmafocus logo
Advanced Search

Pradaxa

Showing 15 posts of 53 posts found.

Stroke crisis to hit UK unless government acts, warns report

December 5, 2011
Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke

Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …

News
Pradaxa

NICE U-turn on Boehringer’s Pradaxa

November 1, 2011
Sales and Marketing NICE, Pradaxa

NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …

News

Boehringer agrees Pradaxa kidney function warning

October 30, 2011
Sales and Marketing AF, EMA, Pradaxa, renal function

Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …

News

Eliquis launched in the UK

September 19, 2011
Sales and Marketing Eliquis, Pradaxa, VTE, Xarelto

Eliquis, the latest entrant to the competitive oral anticoagulant market, has been launched in the UK.Co-developed and co-marketed by Pfizer …

News
Boehringer Ingelheim

Pradaxa and Eliquis gain trial boost over warfarin

August 31, 2011
Sales and Marketing Eliquis, Pradaxa, Xarelto, apixaban

A pair of new blood thinners are superior to warfarin when it comes to reducing the risk of stroke in …

News

NICE wants more information on Pradaxa

August 17, 2011
Sales and Marketing NICE, Pradaxa

NICE has asked for more information on Pradaxa, after deciding in preliminary guidance that the drug is not cost-effective in …

News

Pradaxa approved for stroke prevention in Europe

August 9, 2011
Sales and Marketing Pradaxa, atrial fibrillation, direct thrombin inhibitor

Boehringer Ingelheim’s Pradaxa has become the first drug in 50 years to be approved in Europe for stroke prevention in …

News

Xarelto receives FDA approval

July 4, 2011
Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant

Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …

News
Boehringer Ingelheim

Boehringer’s Pradaxa recommended for expanded European licence

April 18, 2011
Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa

Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …

News
Boehringer Andreas Barner

Boehringer bets on Pradaxa to fill portfolio gaps

April 6, 2011
Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …

News

Merck drops oral anticoagulant

March 25, 2011
Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar

Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …

News

Companies join forces to promote AF awareness

February 16, 2011
Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation

Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …

News

Key drug launches for 2011

January 20, 2011
Sales and Marketing Benlysta, Cladribine, Movectro, Pradaxa, Xarelto, axitinib, boceprevir, crizotinib, telaprevir

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …

Feature

FDA approves Boehringer’s Pradaxa

October 20, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …

News
Pradaxa

FDA committee backs Pradaxa

September 23, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024